Together, the identification of these ECM pathways and the co-expression of AKT3 and DDR2 in E-cadherin-low gastric tumours suggest an active link between ECM remodelling and AKT3 signalling in DGC. This evidence concerns the gene CDH1 and gastric neoplasm.